Vitamin K1 to slow vascular calcification in haemodialysis patients (VitaVasK trial): a rationale and study protocol

Thilo Krueger, Georg Schlieper, Leon Schurgers, Tom Cornelis, Mario Cozzolino, Johannes Jacobi, Michel Jadoul, Markus Ketteler, Lars C. Rump, Peter Stenvinkel, Ralf Westenfeld, Andrzej Wiecek, Sebastian Reinartz, Ralf-Dieter Hilgers, Juergen Floege

Research output: Contribution to journalArticleAcademicpeer-review

16 Citations (Scopus)
Original languageEnglish
Pages (from-to)1633-1638
JournalNephrology Dialysis Transplantation
Volume29
Issue number9
DOIs
Publication statusPublished - Sep 2014

Keywords

  • haemodialysis
  • matrix Gla protein
  • vascular calcification
  • vitamin K

Cite this

Krueger, T., Schlieper, G., Schurgers, L., Cornelis, T., Cozzolino, M., Jacobi, J., Jadoul, M., Ketteler, M., Rump, L. C., Stenvinkel, P., Westenfeld, R., Wiecek, A., Reinartz, S., Hilgers, R-D., & Floege, J. (2014). Vitamin K1 to slow vascular calcification in haemodialysis patients (VitaVasK trial): a rationale and study protocol. Nephrology Dialysis Transplantation, 29(9), 1633-1638. https://doi.org/10.1093/ndt/gft459